The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*

References

• Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179(1):80–86.
   PubMed Web of Science ®Google Scholar
• Naccasha N, Gervasi MT, Chaiworapongsa T, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 2001;185(5):1118–1123.
   PubMed Web of Science ®Google Scholar
• Watts DH, Krohn MA, Wener MH, et al. C-reactive protein in normal pregnancy. Obstet Gynecol. 1991;77(2):176–180.
   PubMed Web of Science ®Google Scholar
• Belo L, Santos-Silva A, Rocha S, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;123(1):46–51.
   PubMed Web of Science ®Google Scholar
• Romero R, Rickles FR, Matthews E, et al. Fibrinopeptide A during normal pregnancy. Am J Perinatol. 1988;5(1):70–73.
   PubMed Web of Science ®Google Scholar
• van Buul EJ, Steegers EA, Jongsma HW, et al. Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med. 1995;46(2):73–85.
   PubMed Web of Science ®Google Scholar
• Manten GT, Franx A, Sikkema JM, et al. Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy. Thromb Res. 2004;114(1):19–23.
   PubMed Web of Science ®Google Scholar
• Gallery ED, Raftos J, Gyory AZ, et al. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension. Aust NZ J Med. 1981;11(3):243–245.
   PubMedGoogle Scholar
• Jagadeesan V. Serum complement levels in normal pregnancy and pregnancy-induced hypertension. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 1988;26(3):389–391.
   PubMed Web of Science ®Google Scholar
• Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med. 2005;17(4):239–245.
   PubMed Web of Science ®Google Scholar
• Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7(10):803–815.
   PubMed Web of Science ®Google Scholar
• Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398–406.
   PubMed Web of Science ®Google Scholar
• Pate M, Damarla V, Chi DS, et al. Endothelial cell biology: role in the inflammatory response. Adv Clin Chem. 2010;52:109–130.
   PubMed Web of Science ®Google Scholar
• Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers. 2011;16(Suppl1):S11–S21.
   Web of Science ®Google Scholar
• Liao JK. Linking endothelial dysfunction with endothelial cell activation. J Clin Invest. 2013;123(2):540–541.
   PubMed Web of Science ®Google Scholar
• Radi ZA, Kehrli ME Jr, Ackermann MR. Cell adhesion molecules, leukocyte trafficking, and strategies to reduce leukocyte infiltration. J Vet Intern Med. 2001;15(6):516–529.
   PubMed Web of Science ®Google Scholar
• Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol. 2008;172(1):1–7.
   PubMed Web of Science ®Google Scholar
• Nourshargh S, Alon R. Leukocyte migration into inflamed tissues. Immunity. 2014;41(5):694–707.
   PubMed Web of Science ®Google Scholar
• Gerhardt T, Ley K. Monocyte trafficking across the vessel wall. Cardiovasc Res. 2015;107(3):321–330.
   PubMed Web of Science ®Google Scholar
• Muller WA. The regulation of transendothelial migration: new knowledge and new questions. Cardiovasc Res. 2015;107(3):310–320.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Nelson RM. Selectins. J Clin Invest. 1993;91(2):379–387.
   PubMed Web of Science ®Google Scholar
• Petruzzelli L, Takami M, Humes HD. Structure and function of cell adhesion molecules. Am J Med. 1999;106(4):467–476.
   PubMed Web of Science ®Google Scholar
• Kneuer C, Ehrhardt C, Radomski MW, et al. Selectins – potential pharmacological targets? Drug Discov Today. 2006;11(21–22):1034–1040.
   PubMed Web of Science ®Google Scholar
• Smith CW. Adhesion molecules and receptors. J Allergy Clin Immunol. 2008;121(2 Suppl):S375–S9; quiz S414.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Ley K, McEver RP, et al. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118(26):6743–6751.
   PubMed Web of Science ®Google Scholar
• Telen MJ. Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors. Hematol Oncol Clin North Am. 2014;28(2):341–354.
   PubMed Web of Science ®Google Scholar
• Garton KJ, Gough PJ, Raines EW. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol. 2006;79(6):1105–1116.
   PubMed Web of Science ®Google Scholar
• Abe E, Matsubara K, Ochi H, et al. Elevated levels of adhesion molecules derived from leukocytes and endothelial cells in patients with pregnancy-induced hypertension. Hypertens Pregnancy. 2003;22(1):31–43.
   PubMed Web of Science ®Google Scholar
• Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18(5):723–731.
   PubMed Web of Science ®Google Scholar
• Austgulen R, Lien E, Vince G, et al. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 1997;71(1):53–58.
   PubMed Web of Science ®Google Scholar
• Kim SY, Ryu HM, Yang JH, et al. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci. 2004;19(5):688–692.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001;185(4):792–797.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Gervasi MT, Refuerzo J, et al. Maternal lymphocyte subpopulations (CD45RA + and CD45RO+) in preeclampsia. Am J Obstet Gynecol. 2002;187(4):889–893.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Preeclampsia and the systemic inflammatory response. Semin Nephrol. 2004;24(6):565–570.
   PubMed Web of Science ®Google Scholar
• Chaemsaithong P, Chaiworapongsa T, Romero R, et al. Maternal plasma soluble TRAIL is decreased in preeclampsia. J Matern Fetal Neonatal Med. 2014;27(3):217–227.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol. 2013;208(4):287.e1–287.e15.
   PubMed Web of Science ®Google Scholar
• Bouwland-Both MI, Steegers EA, Lindemans J, et al. Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study. Am J Obstet Gynecol. 2013;209(2):121.e1–121.11.
   PubMed Web of Science ®Google Scholar
• Johnston TA, Greer IA, Dawes J, et al. Neutrophil activation in small for gestational age pregnancies. Br J Obstet Gynaecol. 1991;98(1):105–106.
   PubMedGoogle Scholar
• Sabatier F, Bretelle F, D’Ercole C, et al. Neutrophil activation in preeclampsia and isolated intrauterine growth restriction. Am J Obstet Gynecol. 2000;183(6):1558–1563.
   PubMed Web of Science ®Google Scholar
• Phocas I, Rizos D, Papoulias J, et al. A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. J Perinatol. 2000;20(2):114–119.
   PubMedGoogle Scholar
• Bretelle F, Sabatier F, Blann A, et al. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia. BJOG. 2001;108(12):1277–1282.
   PubMed Web of Science ®Google Scholar
• Johnson MR, Anim-Nyame N, Johnson P, et al. Does endothelial cell activation occur with intrauterine growth restriction? BJOG. 2002;109(7):836–839.
   PubMed Web of Science ®Google Scholar
• Coata G, Pennacchi L, Bini V, et al. Soluble adhesion molecules: marker of pre-eclampsia and intrauterine growth restriction. J Matern Fetal Neonatal Med. 2002;12(1):28–34.
   PubMedGoogle Scholar
• Crispi F, Domínguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195(1):201–207.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Gotsch F, et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med. 2008;21(1):25–40.
   PubMed Web of Science ®Google Scholar
• Oggé G, Romero R, Chaiworapongsa T, et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med. 2010;23(6):476–487.
   PubMed Web of Science ®Google Scholar
• Soto E, Richani K, Romero R, et al. Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med. 2005;17(4):247–252.
   PubMed Web of Science ®Google Scholar
• Mazaki-Tovi S, Vaisbuch E, Romero R, et al. Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis. Am J Reprod Immunol. 2010;63(3):252–262.
   PubMed Web of Science ®Google Scholar
• Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015;28(14):1621–1632.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol. 2001;185(5):1124–1129.
   PubMed Web of Science ®Google Scholar
• Assi F, Fruscio R, Bonardi C, et al. PENTRAXIN 3 in plasma and vaginal fluid in women with preterm delivery. BJOG. 2007;114(2):143–147.
   PubMed Web of Science ®Google Scholar
• Cruciani L, Romero R, Vaisbuch E, et al. PENTRAXIN 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation. The Journal of Maternal-Fetal & Neonatal Medicine. 2010;23(10):1097–1105.
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Naccasha N, et al. Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2002;11(3):171–175.
   PubMedGoogle Scholar
• Greer IA, Lyall F, Perera T, et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84(6):937–940.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA, Boswell F, et al. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol. 1994;101(6):485–487.
   PubMedGoogle Scholar
• Meekins JW, McLaughlin PJ, West DC, et al. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol. 1994;98(1):110–114.
   PubMed Web of Science ®Google Scholar
• Fickling SA, Whitley GS, Nussey SS. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol. 1995;102(2):173–174.
   PubMedGoogle Scholar
• Halim A, Kanayama N, el Maradny E, et al. Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol. 1996;174(1 Pt 1):272–277.
   PubMed Web of Science ®Google Scholar
• Djurovic S, Schjetlein R, Wisløff F, et al. Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in pre-eclampsia. Br J Obstet Gynaecol. 1997;104(4):466–470.
   PubMedGoogle Scholar
• Krauss T, Kuhn W, Lakoma C, et al. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 1997;177(2):443–449.
   PubMed Web of Science ®Google Scholar
• Airoldi L, Gaffuri B, Rossi G, et al. Soluble intercellular adhesion molecule-1 serum profile in physiologic and preeclamptic pregnancy. Am J Reprod Immunol. 1998;39(3):183–188.
   PubMed Web of Science ®Google Scholar
• Budak E, Madazli R, Aksu MF, et al. Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 1998;63(2):115–121.
   PubMed Web of Science ®Google Scholar
• Daniel Y, Kupferminc MJ, Baram A, et al. Plasma soluble endothelial selectin is elevated in women with pre-eclampsia. Hum Reprod. 1998;13(12):3537–3541.
   PubMed Web of Science ®Google Scholar
• Higgins JR, Papayianni A, Brady HR, et al. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol. 1998;179(2):464–469.
   PubMed Web of Science ®Google Scholar
• Hubel CA, Lyall F, Weissfeld L, et al. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metab Clin Exp. 1998;47(10):1281–1288.
   PubMed Web of Science ®Google Scholar
• Krauss T, Osmers R, Beran J, et al. Soluble adhesion molecules in patients with pre-eclampsia. Losliche Adhasionsmolekule bei Patientinnen mit Praeklampsie. Zentralbl Gynakol. 1998;120(6):279–283.
   PubMedGoogle Scholar
• Daniel Y, Kupferminc MJ, Baram A, et al. A selective increase in plasma soluble vascular cell adhesion molecule-1 levels in preeclampsia. Am J Reprod Immunol. 1999;41(6):407–412.
   PubMed Web of Science ®Google Scholar
• Heyl W, Handt S, Reister F, et al. The role of soluble adhesion molecules in evaluating endothelial cell activation in preeclampsia. Am J Obstet Gynecol. 1999;180(1 Pt 1):68–72.
   PubMed Web of Science ®Google Scholar
• Heyl W, Handt S, Reister F, et al. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol. 1999;86(1):35–41.
   PubMed Web of Science ®Google Scholar
• Madazli R, Budak E, Calay Z, et al. Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia. BJOG. 2000;107(4):514–518.
   PubMed Web of Science ®Google Scholar
• Acar A, Altinbaş A, Oztürk M, et al. Selectins in normal pregnancy, pre-eclampsia and missed abortus. Haematologica. 2001;31(1):33–38.
   Web of Science ®Google Scholar
• Bowen RS, Moodley J, Dutton MF, et al. Systemic inflammatory indices in pre-eclampsia and eclampsia. J Obstet Gynaecol J Inst Obstet Gynaecol. 2001;21(6):563–569.
   PubMedGoogle Scholar
• Oyama R. The relationship between the level of expression of intercellular adhesion molecule-1 in placenta and onset of preeclampsia. J Obstet Gynaecol Res. 2001;27(3):147–154.
   PubMed Web of Science ®Google Scholar
• Aksoy H, Kumtepe Y, Akçay F, et al. Correlation of p-selectin and lipoprotein(a), and other lipid parameters in preeclampsia. Clin Exp Med. 2002;2(1):39–43.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Yoshimatsu J, et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med. 2002;12(1):19–27.
   PubMedGoogle Scholar
• Aliefendioğlu D, Erdem G, Tülek N, et al. Neonatal and maternal serum levels of soluble ICAM-1 in preeclamptic and normal pregnancies. Am J Perinatol. 2002;19(6):333–339.
   PubMed Web of Science ®Google Scholar
• Visser W, Beckmann I, Knook MA, et al. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta obstet gynecol Scand. 2002;81(8):713–719.
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Smárason AK, Muttukrishna S, et al. Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy. 2003;22(1):45–55.
   PubMed Web of Science ®Google Scholar
• Anim-Nyame N, Sooranna SR, Johnson MR, et al. Impaired retrograde transmission of vasodilatory signals via the endothelium in pre-eclampsia: a cause of reduced tissue blood flow? Clin Sci (Lond). 2004;106(1):19–25.
   PubMed Web of Science ®Google Scholar
• Aydin S, Benian A, Madazli R, et al. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004;113(1):21–25.
   PubMed Web of Science ®Google Scholar
• Hanisch CG, Pfeiffer KA, Schlebusch H, et al. Adhesion molecules, activin and inhibin – candidates for the biochemical prediction of hypertensive diseases in pregnancy? Arch Gynecol Obstet. 2004;270(2):110–115.
   PubMedGoogle Scholar
• Ramsay JE, Ferrell WR, Crawford L, et al. Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens. 2004;22(11):2177–2183.
   PubMed Web of Science ®Google Scholar
• Vadachkoria S, Sanchez SE, Qiu C, et al. Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia. Gynecol Obstet Invest. 2004;58(3):133–139.
   PubMed Web of Science ®Google Scholar
• Donker RB, Molema G, Faas MM, et al. Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig. 2005;12(7):518–528.
   PubMedGoogle Scholar
• Heyl W, Heintz B, Reister F, et al. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm. J Perinat Med. 2005;33(2):144–148.
   PubMed Web of Science ®Google Scholar
• Vadachkoria S, Woelk GB, Mahomed K, et al. Elevated soluble vascular cell adhesion molecule-1, elevated Homocyst(e)inemia, and hypertriglyceridemia in relation to preeclampsia risk. Am J Hypertens. 2006;19(3):235–242.
   PubMed Web of Science ®Google Scholar
• Lok CA, Nieuwland R, Sturk A, et al. Microparticle-associated p-selectin reflects platelet activation in preeclampsia. Platelets. 2007;18(1):68–72.
   PubMed Web of Science ®Google Scholar
• Chavarría ME, Lara-González L, García-Paleta Y, et al. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):157–164.
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, et al. sP-selectin in preeclamptic pregnancies with intrauterine normal growth and small-for-gestational-age foetus. Preliminary communication. Med wieku rozwoj. 2009;13(3):212–217.
   PubMedGoogle Scholar
• Lok CA, Jebbink J, Nieuwland R, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol. 2009;61(5):346–359.
   PubMed Web of Science ®Google Scholar
• Lewis DF, Canzoneri BJ, Gu Y, et al. Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Am J Reprod Immunol. 2010;64(6):376–383.
   PubMed Web of Science ®Google Scholar
• Mori T, Shinohara K, Wakatsuki A, et al. Adipocytokines and endothelial function in preeclamptic women. Hypertens Res. 2010;33(3):250–254.
   PubMed Web of Science ®Google Scholar
• Papakonstantinou K, Economou E, Hasiakos D, et al. Antepartum and postpartum maternal plasma levels of E-selectin in pre-eclampsia, gestational proteinuria and gestational hypertension. Eur J Obstet Gynecol Reprod Biol. 2010;153(1):112–113.
   PubMed Web of Science ®Google Scholar
• Robb AO, Din JN, Mills NL, et al. The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation. Thromb Haemost. 2010;103(2):372–378.
   PubMed Web of Science ®Google Scholar
• Strijbos MH, Snijder CA, Kraan J, et al. Levels of circulating endothelial cells in normotensive and severe preeclamptic pregnancies. Cytometry B Clin Cytometry. 2010;78(6):382–386.
   PubMed Web of Science ®Google Scholar
• Szarka A, Rigó J Jr, Lázár L, et al. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010;11:59.
   PubMed Web of Science ®Google Scholar
• Molvarec A, Szarka A, Walentin S, et al. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia. Clin Chim Acta. 2011;412(21–22):1957–1962.
   PubMed Web of Science ®Google Scholar
• Molvarec A, Szarka A, Walentin S, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol. 2011;9:124.
   PubMed Web of Science ®Google Scholar
• Veas CJ, Aguilera VC, Muñoz IJ, et al. Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia. J Matern Fetal Neonatal Med. 2011;24(11):1371–1377.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhou SF, Zhou R, et al. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Hypertens Pregnancy. 2011;30(3):347–358.
   PubMed Web of Science ®Google Scholar
• Carty DM, Anderson LA, Freeman DJ, et al. Early pregnancy soluble E-selectin concentrations and risk of preeclampsia. J Hypertens. 2012;30(5):954–959.
   PubMed Web of Science ®Google Scholar
• Fei X, Hongxiang Z, Qi C, et al. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia. Adv Clin Exp Med. 2012;21(5):573–579.
   PubMed Web of Science ®Google Scholar
• Mehrabian F, Jazi SM, Javanmard SH, et al. Circulating endothelial cells (CECs) and E-selectin: predictors of preeclampsia. J Res Med Sci Off J Isfahan Univ Med Sci. 2012;17(1):15–21.
   PubMedGoogle Scholar
• Farzadnia M, Ayatollahi H, Hasan-Zade M, et al. A comparative study of vascular cell adhesion molecule-1 and high-sensitive C-reactive protein in normal and preeclamptic pregnancies. Interv Med Appl Sci. 2013;5(1):26–30.
   PubMedGoogle Scholar
• Laskowska M, Laskowska K, Oleszczuk J. Elevated maternal serum sP-selectin levels in preeclamptic pregnancies with and without intrauterine fetal growth restriction, but not in normotensive pregnancies complicated by isolated IUGR. Med Sci Monit Int Med J Exp Clin Res. 2013;19:118–124.
   Google Scholar
• Wei SQ, Audibert F, Luo ZC, et al. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors, and preeclampsia. Am J Obstet Gynecol. 2013;208(5):390.e1–390.e6.
   PubMed Web of Science ®Google Scholar
• Nasrollahi S, Hoseini Panah SM, Tavilani H, et al. Antioxidant status and serum levels of selectins in pre-eclampsia. J Obstet Gynaecol J Inst Obstet Gynaecol. 2015;35(1):16–18.
   PubMed Web of Science ®Google Scholar
• Tuzcu ZB, Asicioglu E, Sunbul M, et al. Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. Am J Obstet Gynecol. 2015;213(4):533.e1–533.e7.
   PubMed Web of Science ®Google Scholar
• Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–168.
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159–167.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. 2013. ISBN 978-1-934984-28-4.
   Google Scholar
• von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22(2):143–148.
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Morris GB, Mickal A. Acute pyelonephritis of pregnancy: a clinical review. Obstet Gynecol. 1973;42(1):112–117.
   PubMed Web of Science ®Google Scholar
• Gilstrap LC III, Cunningham FG, Whalley PJ. Acute pyelonephritis in pregnancy: an anterospective study. Obstet Gynecol. 1981;57(4):409–413.
   PubMed Web of Science ®Google Scholar
• Kurmanavicius J, Florio I, Wisser J, et al. Reference resistance indices of the umbilical, fetal middle cerebral and uterine arteries at 24–42 weeks of gestation. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 1997;10(2):112–120.
   PubMed Web of Science ®Google Scholar
• Arduini D, Rizzo G. Normal values of pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med. 1990;18(3):165–172.
   PubMed Web of Science ®Google Scholar
• Trudinger BJ, Cook CM, Giles WB, et al. Fetal umbilical artery velocity waveforms and subsequent neonatal outcome. Br J Obstet Gynaecol. 1991;98(4):378–384.
   PubMedGoogle Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Rizzo V, McIntosh DP, Oh P, et al. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem. 1998;273(52):34724–34729.
   PubMed Web of Science ®Google Scholar
• Garcia-Cardeña G, Comander J, Anderson KR, et al. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA. 2001;98(8):4478–4485.
   PubMed Web of Science ®Google Scholar
• Koo A, Nordsletten D, Umeton R, et al. In silico modeling of shear-stress-induced nitric oxide production in endothelial cells through systems biology. Biophys J. 2013;104(10):2295–2306.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Majeau GR, et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160(2):618–623.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Wheeler ME, et al. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985;76(5):2003–2011.
   PubMed Web of Science ®Google Scholar
• Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA. 1987;84(24):9238–9242.
   PubMed Web of Science ®Google Scholar
• Yong K, Khwaja A. Leucocyte cellular adhesion molecules. Blood Rev. 1990;4(4):211–225.
   PubMed Web of Science ®Google Scholar
• Jutila MA. Leukocyte traffic to sites of inflammation. APMIS. 1992;100(3):191–201.
   PubMed Web of Science ®Google Scholar
• Williams TJ, Hellewell PG. Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response. Am Rev Respir Dis. 1992;146(5 Pt 2):S45–S50.
   PubMed Web of Science ®Google Scholar
• Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504–512.
   PubMed Web of Science ®Google Scholar
• Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323(1):22–27.
   PubMed Web of Science ®Google Scholar
• Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol. 1992;119(1):229–238.
   PubMed Web of Science ®Google Scholar
• Xing K, Murthy S, Liles WC, et al. Clinical utility of biomarkers of endothelial activation in sepsis – a systematic review. Crit Care. 2012;16(1):R7.
   PubMed Web of Science ®Google Scholar
• Zonneveld R, Martinelli R, Shapiro NI, et al. Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit Care. 2014;18(2):204.
   Web of Science ®Google Scholar
• Nakae H, Endo S, Sato N, et al. Involvement of soluble adhesion molecules in acute pancreatitis. Eur Surg Res Eur Chir Forsch Recherches Chir Eur. 2001;33(5–6):377–382.
   PubMed Web of Science ®Google Scholar
• Powell JJ, Siriwardena AK, Fearon KC, et al. Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med. 2001;29(3):567–572.
   PubMed Web of Science ®Google Scholar
• Shingu M, Hashimoto M, Nobunaga M, et al. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients. Inflammation. 1994;18(1):23–34.
   PubMed Web of Science ®Google Scholar
• Krenn V, Schedel J, Döring A, et al. Endothelial cells are the major source of sICAM-1 in rheumatoid synovial tissue. Rheumatol Int. 1997;17(1):17–27.
   PubMed Web of Science ®Google Scholar
• Volin MV. Soluble adhesion molecules in the pathogenesis of rheumatoid arthritis. Curr Pharm Des. 2005;11(5):633–653.
   PubMed Web of Science ®Google Scholar
• Makrilia N, Kollias A, Manolopoulos L, et al. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009;27(10):1023–1037.
   PubMed Web of Science ®Google Scholar
• van Kilsdonk JW, van Kempen LC, van Muijen GN, et al. Soluble adhesion molecules in human cancers: sources and fates. Eur J Cell Biol. 2010;89(6):415–427.
   PubMed Web of Science ®Google Scholar
• Sircar M, Thadhani R, Karumanchi SA. Pathogenesis of preeclampsia. Curr Opin Nephrol Hypertens. 2015;24:131–138.
   PubMed Web of Science ®Google Scholar
• Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996;175(5):1365–1370.
   PubMed Web of Science ®Google Scholar
• Broughton Pipkin F, Roberts JM. Hypertension in pregnancy. J Hum Hypertens. 2000;14(10–11):705–724.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol. 2004;191(4):1061–1062.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243–1249.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–1594.
   PubMed Web of Science ®Google Scholar
• Romero R. Prenatal medicine: the child is the father of the man. J MaternFetal Neonat Med. 1996;2009(22 (8)):636–639.
   Google Scholar
• Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med. 2009;22(8):633–635.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hypertens Rep. 2015;17(11):83.
   PubMed Web of Science ®Google Scholar
• Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens. 1976;5:115–127.
   PubMedGoogle Scholar
• Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4(3):573–593.
   PubMed Web of Science ®Google Scholar
• Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol. 1981;88(7):695–705.
   PubMedGoogle Scholar
• Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–1204.
   PubMed Web of Science ®Google Scholar
• Harrington KF, Campbell S, Bewley S, et al. Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol. 1991;42:S14–S20.
   PubMed Web of Science ®Google Scholar
• Harrington K, Cooper D, Lees C, et al. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 1996;7(3):182–188.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240–249.
   PubMed Web of Science ®Google Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179(5):1359–1375.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):5–15.
   PubMedGoogle Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol. 2000;96(4):559–564.
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Bindra R, et al. Multicenter screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2001;18(5):441–449.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147–160.
   PubMed Web of Science ®Google Scholar
• Myatt L. Role of placenta in preeclampsia. Endocrine. 2002;19(1):103–111.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173–192.
   PubMed Web of Science ®Google Scholar
• Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18(3):383–396.
   PubMed Web of Science ®Google Scholar
• Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol. 2004;2:53.
   PubMedGoogle Scholar
• Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541–H550.
   PubMed Web of Science ®Google Scholar
• Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011;39(6):641–652.
   PubMed Web of Science ®Google Scholar
• Espinoza J. Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia. Expert Opin Med Diagn. 2012;6(2):121–130.
   PubMedGoogle Scholar
• Espinoza J. Uteroplacental ischemia in early- and late-onset pre-eclampsia: a role for the fetus? Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2012;40(4):373–382.
   PubMed Web of Science ®Google Scholar
• George EM, Granger JP. Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. Hypertension. 2012;60(2):507–511.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38(3):139–145.
   PubMed Web of Science ®Google Scholar
• Bosco C, Díaz E, Gutiérrez R, et al. A putative role for telocytes in placental barrier impairment during preeclampsia. Med Hypo. 2015;84(1):72–77.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young investigator award. Am J Obstet Gynecol. 2004;190(6):1541–7; discussion 1547.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kim YM, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005;17(1):3–18.
   PubMed Web of Science ®Google Scholar
• Bujold E, Romero R, Chaiworapongsa T, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005;18(1):9–16.
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Nien JK, et al. A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med. 2006;19(10):607–613.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Friel L, et al. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med. 2007;20(11):777–792.
   PubMed Web of Science ®Google Scholar
• Robinson CJ, Johnson DD. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol. 2007;197(2):174.e1–174.e5.
   PubMed Web of Science ®Google Scholar
• Schlembach D, Wallner W, Sengenberger R, et al. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2007;29(4):407–413.
   PubMed Web of Science ®Google Scholar
• Staff AC, Braekke K, Johnsen GM, et al. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol. 2007;197(2):176.e1–176.e6.
   PubMed Web of Science ®Google Scholar
• Stepan H, Krämer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab. 2007;92(7):2831–2834.
   PubMed Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, et al. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007;49(4):818–824.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Eskild A, Nilsen TI, et al. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007;196(3):239.e1–239.e6.
   PubMed Web of Science ®Google Scholar
• Wallner W, Sengenberger R, Strick R, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112(1):51–57.
   PubMed Web of Science ®Google Scholar
• Wikström AK, Larsson A, Eriksson UJ, et al. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007;109(6):1368–1374.
   PubMed Web of Science ®Google Scholar
• Baumann MU, Bersinger NA, Mohaupt MG, et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol. 2008;199(3):266.e1–266.e6.
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Gotsch F, et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med. 2008;21(1):41–52.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic JP, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med. 2008;21(6):389–402.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Espinoza J, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21(5):279–287.
   PubMed Web of Science ®Google Scholar
• Crispi F, Llurba E, Domínguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31(3):303–309.
   PubMed Web of Science ®Google Scholar
• De Vivo A, Baviera G, Giordano D, et al. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta obstet gynecol Scand. 2008;87(8):837–842.
   PubMed Web of Science ®Google Scholar
• Yinon Y, Nevo O, Xu J, et al. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3. Am J Pathol. 2008;172(1):77–85.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009;22(11):1021–1038.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Lockwood CJ, Schatz F, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia. J Matern Fetal Neonatal Med. 2009;22(7):565–570.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Kusanovic JP, et al. Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations. Ultrasound Obstet Gynecol. 2010;35(2):155–162.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Tarca AL, et al. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia. Am J Obstet Gynecol. 2010;202(6):550.e1–550.10.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011;24(10):1187–1207.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25(5):498–507.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaiworapongsa T. Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest. 2013;123(7):2775–2777.
   PubMed Web of Science ®Google Scholar
• Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med. 2013;26(14):1359–1370.
   PubMed Web of Science ®Google Scholar
• Szabo S, Xu Y, Romero R, et al. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Arch. 2013;463(3):445–458.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Korzeniewski SJ, et al. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med. 2014;27(2):132–144.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Whitten AE, et al. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. J MaternFetal Neonat Med. 2015:1–15.
   Web of Science ®Google Scholar
• Meeme A, Buga GA, Mammen M, et al. Angiogenic imbalance as a contributor to the pathophysiology of preeclampsia among black African women. J Matern Fetal Neonat Med. 2016:1–7.
   Web of Science ®Google Scholar
• Cunningham FG, Pritchard JA. Hematologic considerations of pregnancy-induced hypertension. Semin Perinatol. 1978;2(1):29–38.
   PubMed Web of Science ®Google Scholar
• Weenink GH, Treffers PE, Vijn P, et al. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol. 1984;148(8):1092–1097.
   PubMed Web of Science ®Google Scholar
• Romero R, Mazor M, Lockwood CJ, et al. Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension. Am J Perinatol. 1989;6(1):32–38.
   PubMed Web of Science ®Google Scholar
• de Boer K, ten Cate JW, Sturk A, et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1989;160(1):95–100.
   PubMed Web of Science ®Google Scholar
• Cadroy Y, Grandjean H, Pichon J, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol. 1993;100(5):416–420.
   PubMedGoogle Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med. 2002;11(6):362–367.
   PubMedGoogle Scholar
• Dekker G. Prothrombotic mechanisms in preeclampsia. Thromb Res. 2005;115(Suppl1):17–21.
   Web of Science ®Google Scholar
• Erez O, Romero R, Kim SS, et al. Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation. J Matern Fetal Neonatal Med. 2008;21(6):345–355.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Hoppensteadt D, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med. 2008;21(12):855–869.
   PubMed Web of Science ®Google Scholar
• Kenny LC, Baker PN, Cunningham FG. Platelets, coagulation, and the liver. In: Lindheimer MD, Roberts JM, Cunningham GC, editors. Chesley’s hypertensive disorders of pregnancy. San Diego: Elsevier; 2009. p. 335–351.
   Google Scholar
• Socol ML, Weiner CP, Louis G, et al. Platelet activation in preeclampsia. Am J Obstet Gynecol. 1985;151(4):494–497.
   PubMed Web of Science ®Google Scholar
• Romero R, Lockwood C, Oyarzun E, et al. Toxemia: new concepts in an old disease. Semin Perinatol. 1988;12(4):302–323.
   PubMed Web of Science ®Google Scholar
• Csaicsich P, Deutinger J, Tatra G. Platelet specific proteins (beta-thromboglobulin and platelet factor 4) in normal pregnancy and in pregnancy complicated by preeclampsia. Arch Gynecol Obstet. 1989;244(2):91–95.
   PubMed Web of Science ®Google Scholar
• Ahmed Y, van Iddekinge B, Paul C, et al. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 1993;100(3):216–220.
   PubMedGoogle Scholar
• Major HD, Campbell RA, Silver RM, et al. Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia. Am J Obstet Gynecol. 2014;210(6):547.e1–547.e7.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens. 1991;4(8):700–708.
   PubMed Web of Science ®Google Scholar
• Clark BA, Halvorson L, Sachs B, et al. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol. 1992;166(3):962–968.
   PubMed Web of Science ®Google Scholar
• Friedman SA, Schiff E, Emeis JJ, et al. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol. 1995;172(1 Pt 1):202–203.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev Reprod. 1996;1(2):107–116.
   PubMedGoogle Scholar
• Taylor RN, de Groot CJ, Cho YK, et al. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):17–31.
   PubMedGoogle Scholar
• Cindrova-Davies TG. Gabor Than Award Lecture 2008: pre-eclampsia – from placental oxidative stress to maternal endothelial dysfunction. Placenta. 2009;30(SupplA):S55–S65.
   Web of Science ®Google Scholar
• Lamarca B. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012;64(4):309–320.
   PubMedGoogle Scholar
• Sandvik MK, Leirgul E, Nygård O, et al. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013;209(6):569.e1–569.e10.
   PubMed Web of Science ®Google Scholar
• Torrado J, Farro I, Zócalo Y, et al. Preeclampsia is associated with increased central aortic pressure, elastic arteries stiffness and wave reflections, and resting and recruitable endothelial dysfunction. Int J Hypertens. 2015;2015:720683.
   PubMed Web of Science ®Google Scholar
• Vinayagam V, Bobby Z, Habeebullah S, et al. Plasma markers of endothelial dysfunction in patients with hypertensive disorders of pregnancy: a pilot study in a South Indian population. J MaternFetal Neonat Med. 2015:1–6.
   Web of Science ®Google Scholar
• Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest. 1992;89(1):210–222.
   PubMed Web of Science ®Google Scholar
• Labarrere CA, Faulk WP. Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens are expressed on endovascular cytotrophoblasts in abnormal pregnancies. Am J Reprod Immunol. 1995;33(1):47–53.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Davis V, Li H, et al. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 1995;9(1):1–14.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Genbacev O, Fisher SJ. The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann NY Acad Sci. 2003;995:73–83.
   PubMed Web of Science ®Google Scholar
• Liu Q, Yan X, Li Y, et al. Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCAM/CD146) expression by intermediate trophoblast. Lab Invest. 2004;84(2):221–228.
   PubMed Web of Science ®Google Scholar
• Brown LM, Lacey HA, Baker PN, et al. E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia. Histochem Cell Biol. 2005;124(6):499–506.
   PubMed Web of Science ®Google Scholar
• Cartwright JE, Balarajah G. Trophoblast interactions with endothelial cells are increased by interleukin-1beta and tumour necrosis factor alpha and involve vascular cell adhesion molecule-1 and alpha4beta1. Exp Cell Res. 2005;304(1):328–336.
   PubMed Web of Science ®Google Scholar
• Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol. 2006;46(4):266–273.
   PubMed Web of Science ®Google Scholar
• Blechschmidt K, Mylonas I, Mayr D, et al. Expression of E-cadherin and its repressor snail in placental tissue of normal, preeclamptic and HELLP pregnancies. Virchows Arch. 2007;450(2):195–202.
   PubMed Web of Science ®Google Scholar
• McEwan M, Lins RJ, Munro SK, et al. Cytokine regulation during the formation of the fetal-maternal interface: focus on cell-cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth Factor Rev. 2009;20(3):241–249.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest. 1997;99(9):2139–2151.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99(9):2152–2164.
   PubMed Web of Science ®Google Scholar
• McMaster MT, Zhou Y, Fisher SJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol. 2004;24(6):540–547.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597–602.
   PubMed Web of Science ®Google Scholar
• Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol. 1981;88(9):876–881.
   PubMedGoogle Scholar
• Hustin J, Foidart JM, Lambotte R. Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. Placenta. 1983;4:489–498.
   PubMed Web of Science ®Google Scholar
• Labarrere C, Alonso J, Manni J, et al. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation. Am J Reprod Immunol Microbiol AJRIM. 1985;7(4):149–155.
   PubMed Web of Science ®Google Scholar
• Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93(10):1049–1059.
   PubMedGoogle Scholar
• Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 1991;98(7):648–655.
   PubMedGoogle Scholar
• Meekins JW, Pijnenborg R, Hanssens M, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101(8):669–674.
   PubMedGoogle Scholar
• Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187(5):1416–1423.
   PubMed Web of Science ®Google Scholar
• Madazli R, Benian A, Ilvan S, et al. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia. J Obstet Gynaecol. 2006;26(1):5–10.
   PubMedGoogle Scholar
• Brosens I, Pijnenborg R, Vercruysse L, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
   PubMed Web of Science ®Google Scholar
• Kim YM, Chaemsaithong P, Romero R, et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion. J Matern Fetal Neonatal Med. 2015;28(17):2001–2009.
   PubMed Web of Science ®Google Scholar
• Birdir C, Fryze J, Frölich S, et al. Impact of maternal serum levels of visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11–13 weeks gestation on small for gestational age births. J Matern Fetal Neonatal Med. 2017;30(6):629–634.
   PubMed Web of Science ®Google Scholar
• Missfelder-Lobos H, Teran E, Lees C, et al. Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet Gynecol. 2002;19(5):443–448.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222(3):222–235.
   PubMed Web of Science ®Google Scholar
• Myatt L, Kossenjans W, Sahay R, et al. Oxidative stress causes vascular dysfunction in the placenta. J MaternFetal Med. 2000;9(1):79–82.
   PubMedGoogle Scholar
• Madazli R, Benian A, Aydin S, et al. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol. 2002;22(5):477–480.
   PubMedGoogle Scholar
• Vaughan JE, Walsh SW. Oxidative stress reproduces placental abnormalities of preeclampsia. Hypertens Pregnancy. 2002;21(3):205–223.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Yung HW, Cindrova-Davies T, et al. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta. 2009;30(SupplA):S43–S48.
   Web of Science ®Google Scholar
• Potdar N, Singh R, Mistry V, et al. First-trimester increase in oxidative stress and risk of small-for-gestational-age fetus. BJOG. 2009;116(5):637–642.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang GY, Wang J, et al. A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia. Am J Obstet Gynecol. 2012;206(5):447.e7–447.e16.
   PubMed Web of Science ®Google Scholar
• Friedman SA, de Groot CJ, Taylor RN, et al. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170(3):838–841.
   PubMed Web of Science ®Google Scholar
• Gilstrap LG, 3rd, Hankins GD, Snyder RR, et al. Acute pyelonephritis in pregnancy. Compr Ther. 1986;12(12):38–42.
   PubMedGoogle Scholar
• Mabie WC, Barton JR, Sibai B. Septic shock in pregnancy. Obstet Gynecol. 1997;90(4 Pt 1):553–561.
   PubMed Web of Science ®Google Scholar
• Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol. 2003;13(2):144–150.
   PubMed Web of Science ®Google Scholar
• Barton JR, Sibai BM. Severe sepsis and septic shock in pregnancy. Obstet Gynecol. 2012;120(3):689–706.
   PubMed Web of Science ®Google Scholar
• Morgan J, Roberts S. Maternal sepsis. Obstet Gynecol Clin North Am. 2013;40(1):69–87.
   PubMed Web of Science ®Google Scholar
• Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014;210(3):219.e1–219.e6.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Gotsch F, et al. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma. J Matern Fetal Neonatal Med. 2010;23(2):167–178.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Espinoza J, et al. Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy. J Matern Fetal Neonatal Med. 2007;20(10):735–744.
   PubMed Web of Science ®Google Scholar
• Soto E, Romero R, Vaisbuch E, et al. Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis. J Matern Fetal Neonatal Med. 2010;23(10):1085–1090.
   PubMed Web of Science ®Google Scholar
• Madan I, Than NG, Romero R, et al. The peripheral whole-blood transcriptome of acute pyelonephritis in human pregnancya. J Perinat Med. 2014;42(1):31–53.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Whitten A, et al. Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa. J Perinat Med. 2013;41(5):485–504.
   PubMed Web of Science ®Google Scholar
• Yokoo A, Hirose T, Matsukawa M, et al. Expression of intercellular adhesion molecule-1 in mice with Pseudomonas-induced pyelonephritis. J Urol. 1998;160(2):592–596.
   PubMed Web of Science ®Google Scholar
• Rui-Mei L, Kara AU, Sinniah R. In situ analysis of adhesion molecule expression in kidneys infected with murine malaria. J Pathol. 1998;185(2):219–225.
   PubMed Web of Science ®Google Scholar
• Bishop GA, Hall BM. Expression of leucocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int. 1989;36(6):1078–1085.
   PubMed Web of Science ®Google Scholar
• Lhotta K, Neumayer HP, Joannidis M, et al. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci (Lond). 1991;81(4):477–481.
   PubMed Web of Science ®Google Scholar
• Brady HR. Leukocyte adhesion molecules and kidney diseases. Kidney Int. 1994;45(5):1285–1300.
   PubMed Web of Science ®Google Scholar
• Cowley HC, Heney D, Gearing AJ, et al. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit Care Med. 1994;22(4):651–657.
   PubMed Web of Science ®Google Scholar
• Endo S, Inada K, Kasai T, et al. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm. 1995–1996;46(4):212–219.
   PubMedGoogle Scholar
• Sessler CN, Windsor AC, Schwartz M, et al. Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med. 1995;151(5):1420–1427.
   PubMed Web of Science ®Google Scholar
• Boldt J, Muller M, Kuhn D, et al. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med. 1996;22(2):122–128.
   PubMed Web of Science ®Google Scholar
• Austgulen R, Arntzen KJ, Haereid PE, et al. Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selectin. Acta paediatr. 1997;86(3):274–280.
   PubMed Web of Science ®Google Scholar
• Kayal S, Jaïs JP, Aguini N, et al. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med. 1998;157(3 Pt 1):776–784.
   PubMed Web of Science ®Google Scholar
• Baines PB, Marzouk O, Thomson AP, et al. Endothelial cell adhesion molecules in meningococcal disease. Arch Dis Child. 1999;80(1):74–76.
   PubMed Web of Science ®Google Scholar
• Weigand MA, Schmidt H, Pourmahmoud M, et al. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med. 1999;27(12):2656–2661.
   PubMed Web of Science ®Google Scholar
• Whalen MJ, Doughty LA, Carlos TM, et al. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Crit Care Med. 2000;28(7):2600–2607.
   PubMed Web of Science ®Google Scholar
• Gbadegesin RA, Cotton SA, Coupes BM, et al. Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis. Arch Dis Child. 2002;86(3):218–221.
   PubMed Web of Science ®Google Scholar
• Figueras-Aloy J, Gómez-López L, Rodríguez-Miguélez JM, et al. Serum soluble ICAM-1, VCAM-1, L-selectin, and p-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. Am J Perinatol. 2007;24(6):331–338.
   PubMed Web of Science ®Google Scholar
• Shapiro NI, Schuetz P, Yano K, et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care. 2010;14(5):R182.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Jones AE, Aird WC, et al. Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension. Shock. 2011;36(2):104–108.
   PubMed Web of Science ®Google Scholar
• Loukovaara M, Ylikorkala O. Serum nitric oxide metabolites and E-selectin in preterm premature rupture of membranes. Acta obstet gynecol Scand. 2003;82(7):616–619.
   PubMed Web of Science ®Google Scholar
• Zou L, Zhang H, Zhu J, et al. The value of the soluable intercellular adhesion molecule-1 levels in matermal serum for determination of occult chorioamnionitis in premature rupture of membranes. J Huazhong Univ Sci Technol Med Sci. 2004;24(2):154–157.
   PubMedGoogle Scholar
• Laudanski P, Raba G, Kuc P, et al. Assessment of the selected biochemical markers in predicting preterm labour. J Matern Fetal Neonatal Med. 2012;25(12):2696–2699.
   PubMed Web of Science ®Google Scholar
• Bartha JL, Fernández-Deudero A, Bugatto F, et al. Inflammation and cardiovascular risk in women with preterm labor. J Womens Health (Larchmt). 2012;21(6):643–648.
   PubMed Web of Science ®Google Scholar
• Chen X, Scholl TO. Maternal biomarkers of endothelial dysfunction and preterm delivery. PLoS One. 2014;9(1):e85716.
   PubMed Web of Science ®Google Scholar
• Saleh AA, Gerbasi FR, Mammen EF, et al. Increased platelet activation in preterm labor. Thromb Res. 1992;65(3):475–477.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Hoppensteadt D, et al. Premature labor: a state of platelet activation? J Perinat Med. 2008;36(5):377–387.
   PubMed Web of Science ®Google Scholar
• Smith GD, Whitley E, Gissler M, et al. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet. 2000;356(9247):2066–2067.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002–2006.
   PubMed Web of Science ®Google Scholar
• Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am J Epidemiol. 2004;159(4):336–342.
   PubMed Web of Science ®Google Scholar
• Catov JM, Newman AB, Roberts JM, et al. Preterm delivery and later maternal cardiovascular disease risk. Epidemiology. 2007;18(6):733–739.
   PubMed Web of Science ®Google Scholar
• Bonamy AK, Parikh NI, Cnattingius S, et al. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124(25):2839–2846.
   PubMed Web of Science ®Google Scholar
• Hastie CE, Smith GC, Mackay DF, et al. Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol. 2011;40(4):914–919.
   PubMed Web of Science ®Google Scholar
• Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med. 2009;22(8):672–687.
   PubMed Web of Science ®Google Scholar
• Ay C, Kaider A, Koder S, et al. Association of elevated soluble p-selectin levels with fetal loss in women with a history of venous thromboembolism. Thromb Res. 2012;129(6):725–728.
   PubMed Web of Science ®Google Scholar
• Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2005;25(7):1321–1324.
   PubMed Web of Science ®Google Scholar
• Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res. 2013;131(3):191–197.
   PubMed Web of Science ®Google Scholar
• Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol. 2004;4(2):133–142.
   PubMed Web of Science ®Google Scholar
• Fernandez HN, Hugli TE. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem. 1978;253(19):6955–6964.
   PubMed Web of Science ®Google Scholar
• Richani K, Romero R, Soto E, et al. Unexplained intrauterine fetal death is accompanied by activation of complement. J Perinat Med. 2005;33(4):296–305.
   PubMed Web of Science ®Google Scholar
• Jagels MA, Daffern PJ, Hugli TE. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology. 2000;46(3):209–222.
   PubMed Web of Science ®Google Scholar
• Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of p-selectin in endothelial cells. J Clin Invest. 1994;94(3):1147–1155.
   PubMed Web of Science ®Google Scholar
• Ferrer-Lopez P, Renesto P, Schattner M, et al. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Am J Physiol. 1990;258(6 Pt 1):C1100–C1107.
   PubMedGoogle Scholar
• Del Conde I, Crúz MA, Zhang H, et al. Platelet activation leads to activation and propagation of the complement system. J Exp Med. 2005;201(6):871–879.
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Grigg SE, et al. Blood platelets activate the classical pathway of human complement. J Thromb Haemost. 2006;4(9):2035–2042.
   PubMed Web of Science ®Google Scholar
• Manthey HD, Woodruff TM, Taylor SM, et al. Complement component 5a (C5a). Int J Biochem Cell Biol. 2009;41(11):2114–2117.
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol. 2010;47(13):2170–2175.
   PubMed Web of Science ®Google Scholar
• Caughey AB, Stotland NE, Washington AE, et al. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005;106(1):156–161.
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2016. NCHS Data Brief. 2017;287(287):1–8.
   Google Scholar
• Miller MA, Sagnella GA, Kerry SM, et al. Ethnic differences in circulating soluble adhesion molecules: the Wandsworth Heart and Stroke Study. Clin Sci (Lond). 2003;104(6):591–598.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Veduta A, Minekawa R, et al. Maternal plasma p-selectin at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Hypertens Pregnancy. 2011;30(3):311–321.
   PubMed Web of Science ®Google Scholar